Klinger JR - Search Results

1

Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension.

Klinger JR, Abman SH, Gladwin MT. Klinger JR, et al. Am J Respir Crit Care Med. 2013 Sep 15;188(6):639-46. doi: 10.1164/rccm.201304-0686PP. Am J Respir Crit Care Med. 2013. PMID: 23822809 Review.

2

The efficacy of inhaled nitric oxide in the treatment of acute respiratory distress syndrome. An evidence-based medicine approach.

Greene JH, Klinger JR. Greene JH, et al. Among authors: klinger jr. Crit Care Clin. 1998 Jul;14(3):387-409. doi: 10.1016/s0749-0704(05)70007-5. Crit Care Clin. 1998. PMID: 9700438

3

Genetic disruption of atrial natriuretic peptide causes pulmonary hypertension in normoxic and hypoxic mice.

Klinger JR, Warburton RR, Pietras LA, Smithies O, Swift R, Hill NS. Klinger JR, et al. Am J Physiol. 1999 May;276(5):L868-74. doi: 10.1152/ajplung.1999.276.5.L868. Am J Physiol. 1999. PMID: 10330043

4

Phytoestrogens restore nitric oxide-mediated relaxation in isolated pulmonary arteries from chronically hypoxic rats.

Karamsetty MR, Klinger JR, Hill NS. Karamsetty MR, et al. Among authors: klinger jr. J Pharmacol Exp Ther. 2001 Jun;297(3):968-74. J Pharmacol Exp Ther. 2001. PMID: 11356918

5

Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension.

Preston IR, Klinger JR, Landzberg MJ, Houtchens J, Nelson D, Hill NS. Preston IR, et al. Among authors: klinger jr. Chest. 2001 Sep;120(3):866-72. doi: 10.1378/chest.120.3.866. Chest. 2001. PMID: 11555522

6

Pulmonary edema caused by inhaled nitric oxide therapy in two patients with pulmonary hypertension associated with the CREST syndrome.

Preston IR, Klinger JR, Houtchens J, Nelson D, Mehta S, Hill NS. Preston IR, et al. Among authors: klinger jr. Chest. 2002 Feb;121(2):656-9. doi: 10.1378/chest.121.2.656. Chest. 2002. PMID: 11834688

7

Inhaled nitric oxide in ARDS.

Klinger JR. Klinger JR. Crit Care Clin. 2002 Jan;18(1):45-68, vi. doi: 10.1016/s0749-0704(03)00064-2. Crit Care Clin. 2002. PMID: 11910732 Review.

8

Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.

Preston IR, Klinger JR, Houtches J, Nelson D, Farber HW, Hill NS. Preston IR, et al. Among authors: klinger jr. Respir Med. 2005 Dec;99(12):1501-10. doi: 10.1016/j.rmed.2005.03.026. Respir Med. 2005. PMID: 15890512 Free article. Clinical Trial.

9

Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.

Steiner MK, Preston IR, Klinger JR, Hill NS. Steiner MK, et al. Among authors: klinger jr. Curr Opin Pharmacol. 2005 Jun;5(3):245-50. doi: 10.1016/j.coph.2004.12.008. Curr Opin Pharmacol. 2005. PMID: 15907910 Review.

10

Pulmonary arterial hypertension: new insights and new hope.

Martin KB, Klinger JR, Rounds SI. Martin KB, et al. Among authors: klinger jr. Respirology. 2006 Jan;11(1):6-17. doi: 10.1111/j.1440-1843.2006.00778.x. Respirology. 2006. PMID: 16423196 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters